AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (453.7 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Clinical Research | Publishing Language: Chinese

Status quo of postoperative depression in elderly patients with coronary heart disease and intervention efficacy of a new anti-depressant escitalopram

Yuting Chen, Yao Dai, Bo Feng( )
Department of Geriatric Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China
Show Author Information

Abstract

Objective

To investigate the status quo and influencing factors of postoperative depression in elderly patients with coronary heart disease (CHD) undergoing percutaneous coronary intervention (PCI), explore the intervention efficacy of a new antidepressant, escitalopram, and determine its effect on inflammatory factors in the patients.

Methods

A total of 146 elderly CHD patients admitted in our hospital from May 2022 to May 2023 were enrolled in the study. At 2 weeks after PCI, patient health questionnaire (PHQ-9) was used to evaluate the depression status. Taking presence or absence of depression after PCI as the dependent variable, binary logistic regression model was employed to analyze the related factors of depression after PCI. A double-blind design study was adopted, and the patients with depression after PCI were randomly divided into antidepressant treatment group (conventional psychological counseling + escitalopram tablets) and control group (conventional psychological counseling + placebo). The treatment compliance was good in the two groups. The effective rate of depression treatment after 6 weeks of intervention and serum levels of interleukin-8 (IL-8) and high-sensitivity C-reactive protein (hs-CRP) before and after treatment were compared between groups. The adverse drug reactions were observed in the two groups. SPSS statistics 26.0 was used for statistical analysis. Data comparison between two groups was performed using t test or Chi-square test depending on data type.

Results

Among the 146 elderly CHD patients, 56 cases (38.36%) were diagnosed with depression after PCI. Taking the presence or absence of depression in the patients after PCI as the dependent variable (Y; no=0, yes=1), binary logistic regression analysis suggested that female (OR=1.578, 95%CI 1.158-2.150), number of implanted stents ≥3 (OR=1.365, 95%CI 1.146-1.625) and sleep disorder (OR=1.478, 95%CI 1.182-1.849) were risk factors for depression in elderly CHD patients after PCI, and high social support level (OR=0.640, 95%CI 0.512-0.800) was its protective factor (P< 0.05). The effective rate of depression treatment was 89.29% (25/28) in the antidepressant treatment group, which was significantly higher than that in the control group (35.71%, 10/28; P< 0.05). After intervention, the serum levels of IL-8 and hs-CRP were reduced in both groups, and the antidepressant treatment group exhibited notably lower IL-8 and hs-CRP levels than the control group (P< 0.05). In antidepressant treatment group, 2 patients had diarrhea at the initial stage of medication, and 1 patient had nausea, and these reactions were improved after adjusting the drug dose.

Conclusion

The incidence of depression is quite high in the elderly CHD patients after PCI. Patients with female, number of implanted stents ≥3 and presence of sleep disorder are more likely to have depression. High social support level is a protective factor for postoperative depression. Postoperative administration of a new antidepressant, escitalopram can effectively alleviate the depression symptoms and attenuate the inflammatory conditions, with high drug safety.

CLC number: R541.4 Document code: A

References

【1】
【1】
 
 
Chinese Journal of Multiple Organ Diseases in the Elderly
Pages 332-338

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Chen Y, Dai Y, Feng B. Status quo of postoperative depression in elderly patients with coronary heart disease and intervention efficacy of a new anti-depressant escitalopram. Chinese Journal of Multiple Organ Diseases in the Elderly, 2026, 25(5): 332-338. https://doi.org/10.11915/j.issn.1671-5403.2026.05.069

2

Views

0

Downloads

0

Crossref

Received: 17 May 2025
Accepted: 18 July 2025
Published: 28 May 2026
© 2026 Chinese Journal of Multiple Organ Diseases in the Elderly